Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

Official record

Identifier

NCT07671092

Recruiting locations

countries

AustraliaNew Zealand

Interventions studied

RYZ211/212

Lead sponsor

RayzeBio, Inc.

Target enrolment

40 participants

Study type

INTERVENTIONAL

Phase

Early Phase 1

Status

Recruiting

First posted

Jun 26, 2026

Last updated on the registry

Sep 29, 2026

Age

18 Years

Sex

ALL

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Are at least 18 years old at the time of signing the informed consent form (ICF)
* Have biopsy proven metastatic UC, HR+ and HER2- breast cancer, TNBC, or NSCLC

Exclusion Criteria:

* For Women of Childbearing Potential: Are pregnant or breastfeeding

Note: Additional criteria may apply and will be assessed by the study site

Indexed under

Breast Cancer